Sign In
Buy STAR
$7.63
+0 (+0%)
At Close: Jun 30, 2023
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
02:45pm, Thursday, 27'th Feb 2025
TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, a
Fannie Mae Announces 2024 STAR Program Results
01:00pm, Tuesday, 25'th Feb 2025
Program Recognizes 29 High-Performing Mortgage Servicers Across Three Key Performance Areas WASHINGTON , Feb. 25, 2025 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) today announced its 2024 Servicer Total
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced initi
ROYAL CARIBBEAN'S NEXT EDITION OF ITS ARTIST DISCOVERY PROGRAM TO SHINE ON STAR OF THE SEAS
10:43am, Thursday, 16'th Jan 2025
The vacation brand's art program will spotlight up-and-coming Caribbean artists on Star of the Seas MIAMI , Jan. 16, 2025 /PRNewswire/ -- More ways to bring to life the heart of the Caribbean, its peo
LIBERTY ALL-STAR® Growth Fund, Inc. Declares Distribution
12:00pm, Monday, 13'th Jan 2025
BOSTON , Jan. 13, 2025 /PRNewswire/ -- The Board of Directors of Liberty All-Star Growth Fund, Inc. (NYSE: ASG) has declared a distribution of $0.12 per share payable on March 10, 2025 to shareholders
KB Home Celebrates Milestone of 200,000 ENERGY STAR Certified Homes Built
08:00am, Wednesday, 11'th Dec 2024
LOS ANGELES--(BUSINESS WIRE)-- #BuiltOnRelationships--KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today marked a significant milestone for the company and indust
Astria Therapeutics: Transformative Proof Of Concept Data In Hereditary Angioedema
08:00am, Wednesday, 27'th Nov 2024
Astria Therapeutics, Inc.'s STAR-0215 shows 90-96% reduction in HAE attack frequency, with a twice-a-year dosing regimen, positioning it as a transformative therapy. The company has a strong cash bala
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence company transforming oncology drug development, and its wholly-owned subsidiary Starlight Therapeutics, focused
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
04:15pm, Wednesday, 13'th Nov 2024
- Dermata nears completion of enrollment in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial - - Dermata continues discussions with potential botulinum toxin partners fo
VSee Health Co-CEO and STAR-TIDES Chair to Discuss Digital Health Transformation and Cybersecurity in Fireside Chat
08:00am, Tuesday, 08'th Oct 2024
BOCA RATON, Fla.--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, announced today that co-C
PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
09:05am, Tuesday, 01'st Oct 2024
The new lab will leverage PacBio's HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia The new lab will leverage PacBio's H
TOYOTA JOINS LATIN MUSIC RISING STAR, DANNY OCEAN, ON LONG-AWAITED NORTH AMERICAN MUSIC TOUR
09:00am, Thursday, 19'th Sep 2024
PLANO, Texas , Sept. 19, 2024 /PRNewswire/ -- Venezuelan singer and songwriter Danny Ocean has launched his highly anticipated "Reflexa" tour across the United States and Canada, electrifying audienc
ROYAL CARIBBEAN'S STAR OF THE SEAS TAKES CENTER STAGE TO DELIVER ULTIMATE FAMILY VACATION
11:45am, Tuesday, 20'th Aug 2024
Starting August 2025, the next combination of every vacation will headline Port Canaveral (Orlando), Florida, with the record-setting lineup of Icon Class experiences MIAMI , Aug. 20, 2024 /PRNewswi
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
04:05pm, Wednesday, 07'th Aug 2024
- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial has enrolled over 50% of patients - Dermata continues discussions with potential botulinum toxin partners for DMT410 - Rai
Reply Showcases Futura, a Digital Tour Expert for Costa Crociere Powered by NVIDIA ACE and Generative AI, at SIGGRAPH 2024
03:30am, Tuesday, 30'th Jul 2024
TURIN, Italy--(BUSINESS WIRE)--Reply, an international group specializing in creating new business models enabled by AI and digital media, today announces its participation at SIGGRAPH 2024, the premi
